HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Kobayashi Selected Research

Amniotic Fluid Embolism

12/2017Squamous cell carcinoma antigen as a novel candidate marker for amniotic fluid embolism.
8/2015Amniotic Fluid Embolism: Anaphylactic Reactions With Idiosyncratic Adverse Response.
4/2014Predictor of mortality in patients with amniotic fluid embolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Kobayashi Research Topics

Disease

112Neoplasms (Cancer)
10/2022 - 08/2002
47Ovarian Neoplasms (Ovarian Cancer)
09/2022 - 08/2002
45Neoplasm Metastasis (Metastasis)
06/2022 - 03/2003
39Endometriosis
12/2021 - 01/2009
27Carcinoma (Carcinomatosis)
09/2021 - 04/2003
25Inflammation (Inflammations)
07/2022 - 05/2003
23Carcinogenesis
03/2022 - 07/2002
15Hemorrhage
12/2021 - 10/2008
11Sarcoma (Soft Tissue Sarcoma)
05/2022 - 09/2004
11Mucopolysaccharidosis II (Hunter Syndrome)
05/2021 - 09/2012
10Glycogen Storage Disease Type II (Pompe's Disease)
01/2017 - 05/2010
9Ovarian Epithelial Carcinoma
02/2022 - 08/2012
9Pre-Eclampsia (Preeclampsia)
01/2020 - 09/2009
8Pain (Aches)
01/2021 - 09/2010
7Hypoxia (Hypoxemia)
01/2022 - 09/2009
7Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2019 - 06/2010
7Endometrial Neoplasms (Endometrial Cancer)
06/2018 - 11/2002
7Hypersensitivity (Allergy)
01/2016 - 05/2009
6Adenomyosis
07/2022 - 03/2013
6Cysts
12/2021 - 07/2012
6Lysosomal Storage Diseases (Lysosomal Storage Disease)
05/2021 - 05/2014
6Mesothelioma
03/2013 - 11/2010
6Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2012 - 05/2003
5Wounds and Injuries (Trauma)
10/2022 - 10/2009
5Residual Neoplasm
01/2022 - 03/2005
5Rheumatoid Arthritis
01/2022 - 07/2003
5Fibrosis (Cirrhosis)
01/2020 - 05/2003
5Osteoarthritis
01/2020 - 10/2013
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2017 - 04/2012
5Menstruation Disturbances
11/2017 - 08/2009
5Premature Obstetric Labor (Premature Labor)
07/2016 - 01/2011
5Hypertension (High Blood Pressure)
04/2014 - 09/2007
5Chondrosarcoma
11/2005 - 03/2002
4Fabry Disease (Fabry's Disease)
06/2022 - 05/2011
4Stomach Neoplasms (Stomach Cancer)
03/2022 - 02/2010
4Ascites
01/2022 - 05/2004
4Infections
06/2021 - 05/2009
4Spontaneous Fractures (Pathological Fracture)
10/2020 - 09/2010
4Lymphatic Metastasis
01/2020 - 09/2010
4Lung Neoplasms (Lung Cancer)
01/2020 - 08/2005
4Premature Birth (Birth, Premature)
01/2020 - 10/2008
4Mucopolysaccharidosis I (Hurler Syndrome)
01/2018 - 05/2005
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2017 - 03/2009

Drug/Important Bio-Agent (IBA)

39Proteins (Proteins, Gene)FDA Link
09/2022 - 08/2002
23Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2022 - 03/2002
22IronIBA
12/2021 - 10/2008
18CytokinesIBA
01/2021 - 04/2003
17Protease Inhibitors (Protease Inhibitor)IBA
01/2013 - 03/2002
14GlycosaminoglycansIBA
05/2021 - 05/2005
13Biomarkers (Surrogate Marker)IBA
02/2022 - 03/2005
13Heme (Haem)IBA
12/2021 - 10/2008
13Messenger RNA (mRNA)IBA
07/2018 - 08/2002
11EnzymesIBA
10/2022 - 09/2002
11AntioxidantsIBA
03/2022 - 03/2006
10GlucosidasesIBA
10/2022 - 11/2011
10Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 08/2009
10Biological ProductsIBA
01/2021 - 05/2003
10Transcription Factors (Transcription Factor)IBA
04/2018 - 04/2003
10LigandsIBA
09/2017 - 08/2009
9AcidsIBA
10/2022 - 11/2011
9Pharmaceutical PreparationsIBA
01/2022 - 08/2009
9Phosphotransferases (Kinase)IBA
12/2021 - 12/2002
8Urokinase Plasminogen Activator ReceptorsIBA
01/2022 - 08/2002
8ErbB Receptors (EGF Receptor)IBA
01/2020 - 12/2010
8Peptide Hydrolases (Proteases)FDA Link
08/2015 - 04/2003
7tissue-factor-pathway inhibitor 2 (PP5)IBA
09/2022 - 08/2015
7Hemoglobins (Hemoglobin)IBA
01/2021 - 01/2015
7DNA (Deoxyribonucleic Acid)IBA
04/2019 - 06/2010
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2011 - 11/2004
6Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2005 - 07/2003
5AntigensIBA
09/2022 - 08/2015
5fibrin fragment D (D-dimer)IBA
02/2022 - 04/2012
5Hormones (Hormone)IBA
12/2021 - 01/2011
5PlatinumIBA
11/2021 - 02/2012
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2018 - 08/2005
5LipopolysaccharidesIBA
01/2016 - 03/2005
5Hepatocyte Nuclear FactorsIBA
11/2013 - 10/2011
4Estrogens (Estrogen)FDA Link
07/2022 - 10/2011
4Plasminogen InactivatorsIBA
01/2022 - 07/2003
4C-Reactive ProteinIBA
06/2021 - 01/2015
4Estrogen ReceptorsIBA
03/2021 - 08/2002
4RNA (Ribonucleic Acid)IBA
01/2021 - 04/2012
4Tyrosine Kinase InhibitorsIBA
01/2021 - 04/2014
4Indicators and Reagents (Reagents)IBA
01/2021 - 09/2004
4Therapeutic UsesIBA
12/2020 - 01/2013
4Dihydrotachysterol (AT 10)IBA
05/2020 - 08/2005
4Hepatocyte Nuclear Factor 1-betaIBA
05/2019 - 04/2009
4Peptides (Polypeptides)IBA
09/2017 - 09/2009
4GlycogenIBA
01/2017 - 05/2010
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016 - 09/2010

Therapy/Procedure

48Therapeutics
07/2022 - 02/2004
29Drug Therapy (Chemotherapy)
06/2022 - 09/2004
17Radiotherapy
05/2021 - 09/2010
12Enzyme Replacement Therapy
12/2020 - 05/2010
9Hysterectomy
01/2020 - 10/2007
8Adjuvant Chemotherapy
05/2022 - 09/2004
6Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021 - 05/2011
5Laparotomy
05/2022 - 04/2013
5Curettage
12/2021 - 12/2017
4Gastrectomy
03/2022 - 02/2010